跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JK-new
首页
药物
JK-new
JK-new
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
New polypeptide-human Jk signal binding protein (IGK JRB) 9.13 and polynucleotide for encoding such polypeptide
CN 1339471 A
申请人: BODE GENE DEV CO LTD SHANGHAI
优先权: 2000
CN
New drug against lung cancer and extraction separation method of new drug
CN 102631371 A
申请人: GUANGZHOU HANFANG PHARMACEUTICAL CO LTD
优先权: 2011
CN
Compound JK-03M having higher protein kinase G inhibitory activity or pharmaceutically acceptable salt thereof and preparation method thereof
CN 108658947 A
申请人: TIANJIN JENKEM TECH CO LTD
优先权: 2017
CN
Nanometer lipid particle containing cationic lipid and application of nanometer lipid particle to self-replicating mRNA (messenger Ribonucleic Acid) delivery system
CN 118026881 A
申请人: NINGBO JUNJIAN BIOLOGICAL TECH CO LTD
优先权: 2024
CN
Synthesis method of 3, 7A-diazacycloheptyl [jk] fluorene derivative
CN 118515667 A
申请人: UNIV SHANXI MEDICAL
优先权: 2024
CN
药物
反馈